# Splicing junction biomarkers from recount3 across cancers (P03)

**Theme:** T1 Pan-cancer transcriptomics | **Year:** 2026

## RQ
Are alternative splicing patterns prognostic across tumor types?

## Hypothesis
Recurrent junction usage predicts outcomes.

## Methods
Differential splicing; survival; cross-cohort validation

## Datasets
recount3 junctions; TCGA
